Second Salvage Autologous Hematopoietic Stem Cell Transplantation in Patients with Relapsed/Refractory Multiple Myeloma in the Era of Novel Agents: Results of the KMM2301 Study
SAT may provide clinical benefit in selected patients with MM, particularly those with a durable response to first ASCT and those undergoing SAT at an earlier line of relapse in the novel agent era.
Authors
- Je-Jung Lee (ORCID: https://orcid.org/0000-0003-1939-4364)
- DO Young Rok
- K. H. Yoo
- Hyungwoo Cho (ORCID: https://orcid.org/0000-0003-4307-2795)
- Jongheon Jung
- Myung-Won Lee
- Jae-Cheol Jo
- Ho-Jin Shin
- Ja Min Byun
- Chang-Ki Min
- Won Sik Lee
- Jae Hoon Lee
- Ji Hyun Lee
- Sang Eun Yoon
- Hye Jin Kang
- Jun Ho Yi
- Sung-Hoon Jung
- Hyeon-Seok Eom
- Ju-Hyun Park
- Seung-Shin Lee
- Sung-Hyun Kim
- Dok Hyun Yoon
- Kihyun Kim
Institutions
- Ulsan College (KR)
- Chungnam National University (KR)
- Dongguk University (KR)
- Asan Medical Center (KR)
- Samsung Medical Center (KR)
- Seoul National University Hospital (KR)
- University of Ulsan (KR)
- Gachon University Gil Medical Center (KR)
- Korea Institute of Radiological and Medical Sciences (KR)
- National Cancer Center (US)
- Inje University Busan Paik Hospital (KR)
- Pusan National University Hospital (KR)
- Keimyung University Dongsan Medical Center (KR)
- Ulsan University Hospital (KR)
- Chonnam National University Hwasun Hospital (KR)
- The Catholic University of Korea Seoul St. Mary's Hospital (KR)
- Dong-A University (KR)
- Keimyung University (KR)
- Chung-Ang University (KR)
- Wonkwang University (KR)
- Catholic University of Korea (KR)
Publication Details
- Journal
- Cancers
- Published
- 2026-01-30
- DOI
- https://doi.org/10.3390/cancers18030471
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00